Literature DB >> 21922527

Possible new LNK mutations in myeloproliferative neoplasms.

Jung-Sook Ha1, Dong-Seok Jeon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21922527     DOI： 10.1002/ajh.22107

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  10 in total

1.  Infrequent occurrence of mutations in the PH domain of LNK in patients with JAK2 mutation-negative 'idiopathic' erythrocytosis.

Authors:  Ambra Spolverini; Lisa Pieri; Paola Guglielmelli; Alessandro Pancrazzi; Tiziana Fanelli; Chiara Paoli; Alberto Bosi; Ilaria Nichele; Marco Ruggeri; Alessandro M Vannucchi
Journal:  Haematologica       Date:  2013-06-28       Impact factor: 9.941

Review 2.  The role of LNK/SH2B3 genetic alterations in myeloproliferative neoplasms and other hematological disorders.

Authors:  N Maslah; B Cassinat; E Verger; J-J Kiladjian; L Velazquez
Journal:  Leukemia       Date:  2017-05-09       Impact factor: 11.528

Review 3.  12q24 locus association with type 1 diabetes: SH2B3 or ATXN2?

Authors:  Georg Auburger; Suzana Gispert; Suna Lahut; Ozgür Omür; Ewa Damrath; Melanie Heck; Nazlı Başak
Journal:  World J Diabetes       Date:  2014-06-15

4.  SH2B3 (LNK) mutations from myeloproliferative neoplasms patients have mild loss of function against wild type JAK2 and JAK2 V617F.

Authors:  Maya Koren-Michowitz; Sigal Gery; Takayuki Tabayashi; Dechen Lin; Rocio Alvarez; Arnon Nagler; H Phillip Koeffler
Journal:  Br J Haematol       Date:  2013-04-17       Impact factor: 6.998

5.  Ruxolitinib: a potent and selective Janus kinase 1 and 2 inhibitor in patients with myelofibrosis. An update for clinicians.

Authors:  Claire Harrison; Alessandro M Vannucchi
Journal:  Ther Adv Hematol       Date:  2012-12

Review 6.  Genetic Alterations of the Thrombopoietin/MPL/JAK2 Axis Impacting Megakaryopoiesis.

Authors:  Isabelle Plo; Christine Bellanné-Chantelot; Matthieu Mosca; Stefania Mazzi; Caroline Marty; William Vainchenker
Journal:  Front Endocrinol (Lausanne)       Date:  2017-09-12       Impact factor: 5.555

7.  Genome-wide association study in a Korean population identifies six novel susceptibility loci for rheumatoid arthritis.

Authors:  Young-Chang Kwon; Jiwoo Lim; So-Young Bang; Eunji Ha; Mi Yeong Hwang; Kyungheon Yoon; Jung-Yoon Choe; Dae-Hyun Yoo; Shin-Seok Lee; Jisoo Lee; Won Tae Chung; Tae-Hwan Kim; Yoon-Kyoung Sung; Seung-Cheol Shim; Chan-Bum Choi; Jae-Bum Jun; Young Mo Kang; Jung-Min Shin; Yeon-Kyung Lee; Soo-Kyung Cho; Bong-Jo Kim; Hye-Soon Lee; Kwangwoo Kim; Sang-Cheol Bae
Journal:  Ann Rheum Dis       Date:  2020-07-28       Impact factor: 19.103

8.  LNK (SH2B3): paradoxical effects in ovarian cancer.

Authors:  L-W Ding; Q-Y Sun; D-C Lin; W Chien; N Hattori; X-M Dong; S Gery; M Garg; N B Doan; J W Said; J-F Xiao; H Yang; L-Z Liu; X Meng; R Y-J Huang; K Tang; H P Koeffler
Journal:  Oncogene       Date:  2014-04-07       Impact factor: 9.867

9.  Mutational analysis of SH2B3 in Korean patients with BCR-ABL1 negative myeloproliferative neoplasm.

Authors:  Namhee Kim; In Suk Kim; Chulhun Ludgerus Chang; Eun Yup Lee; Hyung Hoi Kim; Moo Kon Song; Ho Jin Shin; Joo Seop Chung
Journal:  Ann Lab Med       Date:  2016-01       Impact factor: 3.464

10.  Assessment of the clinical utility of four NGS panels in myeloid malignancies. Suggestions for NGS panel choice or design.

Authors:  Almudena Aguilera-Diaz; Iria Vazquez; Beñat Ariceta; Amagoia Mañú; Zuriñe Blasco-Iturri; Sara Palomino-Echeverría; María José Larrayoz; Ramón García-Sanz; María Isabel Prieto-Conde; María Del Carmen Chillón; Ana Alfonso-Pierola; Felipe Prosper; Marta Fernandez-Mercado; María José Calasanz
Journal:  PLoS One       Date:  2020-01-24       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.